Pharmaceutical firms are turning to AI to find new molecules that might be able to tackle disease.
Source link
Snapchat joins other platforms in the fight against ‘AI slop’
As Chris Best, the co-founder and chief executive of Substack put it last week: "It's getting harder to tell...














































